Ultromics designed EchoGo Amyloidosis to evaluate routine echocardiogram results for signs of cardiac amyloidosis. It received the FDA's breakthrough device designation back in 2023.

Medtronic has launched new research into AI's potential to identify patients with severe aortic stenosis and other worrying symptoms. The company hopes to overcome longstanding health disparities and reach individuals who may otherwise go untreated.

“When we rely too much on whatever the computer tells us, that’s a problem."

By expediting communication between radiologists and referring providers when suspicious findings are identified, the system has great potential to improve clinical outcomes in real-world scenarios, authors of a new study in JACR suggest.

Black-box outputs aren’t just a problem with AI. They’re also a problem with physicians. 

The pace of AI adoption is quickening in the sector, which includes biopharmaceuticals, digital health, clinical diagnostics and medical devices.

Hadley Wilson, MD, spoke to Cardiovascular Business at the three-day event to discuss key late-breaking studies and trends. Topics included new drug treatments, AI and much more.

A new analysis in Academic Radiology dives into the importance of finding balance between reducing radiation exposure while maintaining image quality.